{"title":"Référentiel de la Société francophone du diabète (SFD) : vaccination chez la personne vivant avec un diabète – 2025","authors":"Société francophone du diabète (SFD)","doi":"10.1016/j.mmm.2025.12.014","DOIUrl":"10.1016/j.mmm.2025.12.014","url":null,"abstract":"","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"20 1","pages":"Pages 73-89"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Surveillance continue de la cétonémie : la nouvelle frontière","authors":"Pierre Yves Benhamou","doi":"10.1016/j.mmm.2025.12.013","DOIUrl":"10.1016/j.mmm.2025.12.013","url":null,"abstract":"","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"20 1","pages":"Pages 1-2"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sabine Baron , Eric Renard , Claire Ballot Schmit , Juliette Eroukhmanoff , Jacques Beltrand , Marc Nicolino , Zeina Salame , Amar Bahloul , Sophie Borot , Fabienne Dalla Vale , Helen Mosnier Pudar , Alfred Penfornis
{"title":"Diabète de type 1 : transition de la pédiatrie à la diabétologie d’adultes – partage de bonnes pratiques","authors":"Sabine Baron , Eric Renard , Claire Ballot Schmit , Juliette Eroukhmanoff , Jacques Beltrand , Marc Nicolino , Zeina Salame , Amar Bahloul , Sophie Borot , Fabienne Dalla Vale , Helen Mosnier Pudar , Alfred Penfornis","doi":"10.1016/j.mmm.2025.05.010","DOIUrl":"10.1016/j.mmm.2025.05.010","url":null,"abstract":"<div><div>Plus de la moitié des personnes vivant avec un diabète de type 1 (DT1) sont diagnostiquées avant l’âge de 20 ans (1). Un des besoins non satisfaits le plus urgent est la gestion de la période de transition entre la pédiatrie et la médecine adulte. Mené sous l’égide d’un comité scientifique composé de pédiatres diabétologues et de diabétologues d’adultes, le projet « TRANSITION DT1 » a eu pour objectif de discuter de l’organisation de la transition ainsi que de comprendre le vécu et les attentes des patients afin de partager les expériences entre pairs et de proposer des outils de bonnes pratiques pour accompagner les professionnels de santé (PDS) dans la gestion de cette transition.</div></div><div><div>More than half of the people living with type 1 diabetes (T1D) are diagnosed before the age of 20 (1). One of the most urgent unmet needs is the management of the transition period between pediatric care and adult medicine. Conducted under the aegis of a scientific committee composed of pediatric diabetologists and adult diabetologists, the “TRANSITION T1D” project aimed to discuss the organization of the transition as well as to understand the experiences and expectations of patients in order to share experiences among peers and propose tools for best practices to support healthcare professionals (HCPs) in managing this transition.</div></div>","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 663-670"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emmanuel Sonnet , Sébastien Le Yaouanq , Gwénaelle Arnault , Anne Cossec , Jean-Marc Malécot , Christine Petit-Simon , Pascal Monguillon , Eva Jali , Noémie Le Tallec , Sophie Nozeran , Elsa Bleichner , Elisabeth Tarasco-Schenrey , Françoise Cueff-Bouroullec , Geneviève Crouzeix , Charlotte Nachtergaele , Philippe Thuillier
{"title":"Évaluation du projet de prise en charge du diabète gestationnel par télésurveillance en Bretagne","authors":"Emmanuel Sonnet , Sébastien Le Yaouanq , Gwénaelle Arnault , Anne Cossec , Jean-Marc Malécot , Christine Petit-Simon , Pascal Monguillon , Eva Jali , Noémie Le Tallec , Sophie Nozeran , Elsa Bleichner , Elisabeth Tarasco-Schenrey , Françoise Cueff-Bouroullec , Geneviève Crouzeix , Charlotte Nachtergaele , Philippe Thuillier","doi":"10.1016/j.mmm.2025.09.001","DOIUrl":"10.1016/j.mmm.2025.09.001","url":null,"abstract":"<div><div>Nous rapportons les résultats d’une expérimentation type « article 51 » qui s’est déroulée dans 13 centres en Bretagne, et concernant un suivi par télésurveillance des patientes ayant un diabète gestationnel, autour de l’outil Candiss. Au total, 4374 femmes ont pu ainsi être suivies, dont un tiers ont bénéficié d’un traitement par insuline. L’évaluation qualitative a montré que la télésurveillance a répondu aux attentes des professionnels de santé et des patientes. Cette nouvelle expérimentation a ainsi permis le remboursement de cette télésurveillance.</div></div><div><div>We report the results of a specific experimentation, located in 13 centers in Brittany, and assessing the Candiss telemedicine tool in the management of patients with gestational diabetes. In all, 4374 women were included, a third of whom received insulin treatment. The qualitative evaluation has been positive for health care professionals and patients. This new experimentation has allowed the reimbursement of this telemedicine tool in France.</div></div>","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 685-702"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Morgane Le Néel , Iva Gueorguieva , Audrey Dupé , Camille Thoraval , Nassima Ramdane , Kiné Fall , Vincent Chouraki , Christine Lefevre
{"title":"Impact de la télésurveillance sur le risque de décompensation du diabète de type 1 chez l’enfant : une étude rétrospective au CHU de Lille","authors":"Morgane Le Néel , Iva Gueorguieva , Audrey Dupé , Camille Thoraval , Nassima Ramdane , Kiné Fall , Vincent Chouraki , Christine Lefevre","doi":"10.1016/j.mmm.2025.05.009","DOIUrl":"10.1016/j.mmm.2025.05.009","url":null,"abstract":"<div><div>Cette étude rétrospective monocentrique a évalué l’impact d’un programme de télésurveillance (DIABHELP) sur la prise en charge du diabète de type 1 chez l’enfant au CHU de Lille. Comparant deux périodes (2013–2018 vs. 2019–2022), l’étude a inclus 388 décompensations. Le risque d’accident aigu était 2,6 fois plus élevé avant la télésurveillance. La non-observance était le principal facteur de risque. Le nombre de décompensations liées aux infections ou au matériel a diminué après la mise en place du programme, tout comme les acidocétoses. Les résultats suggèrent que la télésurveillance améliore la prise en charge, notamment par une meilleure gestion des événements intercurrents, mais son impact est limité en cas de difficultés psychosociales. Un accompagnement individualisé reste essentiel pour optimiser le contrôle glycémique et prévenir les complications.</div></div><div><div>This monocentric retrospective study evaluated the impact of a telemonitoring program (DIABHELP) on the management of type 1 diabetes in children at Lille University Hospital. Comparing two periods (2013–2018 vs. 2019–2022), the study included 388 decompensations. The risk of acute events was 2.6 times higher before the implementation of telemonitoring. Non-adherence was the main risk factor. The number of decompensations related to infections or technical issues decreased after the program was introduced, as did cases of diabetic ketoacidosis. The results suggest that telemonitoring improves disease management, particularly through better handling of intercurrent events, but its impact remains limited in cases of psychosocial difficulties. Individualized support remains essential to optimize glycemic control and prevent complications.</div></div>","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 677-684"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rôle des sphingolipides dans l’insulinorésistance","authors":"Sarah Ali-Berrada, Tony Alghazal, Eric Hajduch","doi":"10.1016/j.mmm.2025.09.002","DOIUrl":"10.1016/j.mmm.2025.09.002","url":null,"abstract":"<div><div>La résistance à l’insuline est une caractéristique du diabète de type 2 et joue un rôle majeur dans la pathogenèse de cette maladie. Bien que les acides gras circulants, dont les concentrations sont fortement augmentées dans le diabète de type 2, jouent un rôle important dans son développement, ils ne sont pas directement impliqués contrairement à certains de leurs dérivés métaboliques tels que les céramides. Cette revue décrit les dernières avancées concernant les céramides et autres sphingolipides en tant qu’acteurs majeurs dans le développement de la résistance à l’insuline.</div></div><div><div>Insulin resistance is a characteristic of type 2 diabetes and plays a major role in the pathogenesis of this disease. Although circulating fatty acids, which are greatly increased in type 2 diabetes, play an important role in its development, they are not directly involved, unlike some of their metabolic derivatives such as ceramides. This review describes the latest advances involving ceramides and other sphingolipids as major players in the development of insulin resistance.</div></div>","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 671-676"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrice Darmon, Bernard Bauduceau, Lyse Bordier, Bruno Detournay, Olivier Dupuy, Pierre Gourdy, François Jornayvaz, Emmanuelle Lecornet-Sokol, Alfred Penfornis, Eric Renard, André Scheen, Ariane Sultan, Tiphaine Vidal-Trecan, pour la SFD
{"title":"Prise de position de la Société Francophone du Diabète (SFD) sur les stratégies d’utilisation des traitements de l’hyperglycémie dans le diabète de type 2 – 2025","authors":"Patrice Darmon, Bernard Bauduceau, Lyse Bordier, Bruno Detournay, Olivier Dupuy, Pierre Gourdy, François Jornayvaz, Emmanuelle Lecornet-Sokol, Alfred Penfornis, Eric Renard, André Scheen, Ariane Sultan, Tiphaine Vidal-Trecan, pour la SFD","doi":"10.1016/j.mmm.2025.10.002","DOIUrl":"10.1016/j.mmm.2025.10.002","url":null,"abstract":"","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 630-662"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145690397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Agonistes du récepteur du GLP-1 et sarcopénie : question émergente ou véritable enjeu clinique ?","authors":"Serge Halimi","doi":"10.1016/j.mmm.2025.10.004","DOIUrl":"10.1016/j.mmm.2025.10.004","url":null,"abstract":"","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Pages 593-596"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements de l’hyperglycémie dans le diabète de type 2–2025","authors":"Éric Renard","doi":"10.1016/j.mmm.2025.10.005","DOIUrl":"10.1016/j.mmm.2025.10.005","url":null,"abstract":"","PeriodicalId":35047,"journal":{"name":"Medecine des Maladies Metaboliques","volume":"19 8","pages":"Page 629"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}